Leerink Partnrs Forecasts Weaker Earnings for agilon health

agilon health, inc. (NYSE:AGL - Free Report) - Investment analysts at Leerink Partnrs cut their FY2024 EPS estimates for agilon health in a research report issued on Monday, November 11th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of ($0.65) per share for the year, down from their prior estimate of ($0.35). The consensus estimate for agilon health's current full-year earnings is ($0.35) per share. Leerink Partnrs also issued estimates for agilon health's Q4 2024 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.19) EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at ($0.39) EPS, FY2026 earnings at ($0.26) EPS, FY2027 earnings at ($0.18) EPS and FY2028 earnings at ($0.07) EPS.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analysts' expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the prior year, the business earned ($0.06) EPS.

A number of other brokerages also recently commented on AGL. Benchmark reissued a "buy" rating and issued a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Citigroup cut their price target on shares of agilon health from $2.50 to $1.75 and set a "sell" rating for the company in a report on Wednesday. Evercore ISI reduced their price target on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on agilon health from $5.00 to $4.00 and set a "hold" rating for the company in a research report on Friday, August 9th. Finally, TD Cowen reduced their price objective on shares of agilon health from $6.00 to $2.00 and set a "hold" rating for the company in a research note on Monday. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $6.38.

agilon health Trading Down 9.0 %

AGL stock traded down $0.17 during midday trading on Thursday, reaching $1.71. 5,638,821 shares of the company's stock traded hands, compared to its average volume of 4,978,740. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a fifty-two week low of $1.70 and a fifty-two week high of $13.76. The business has a 50-day moving average price of $3.14 and a two-hundred day moving average price of $4.90. The company has a market capitalization of $704.55 million, a P/E ratio of -2.01 and a beta of 0.60.

Insider Activity

In other agilon health news, CEO Steven Sell bought 20,000 shares of the firm's stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares of the company's stock, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 3.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its position in agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company's stock worth $176,582,000 after purchasing an additional 371,537 shares in the last quarter. AQR Capital Management LLC increased its position in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter. Susquehanna Fundamental Investments LLC raised its stake in shares of agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock worth $5,262,000 after purchasing an additional 316,856 shares during the period. Capital International Investors boosted its holdings in shares of agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company's stock worth $123,207,000 after buying an additional 9,263,296 shares during the last quarter. Finally, Simplicity Wealth LLC grew its position in agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company's stock valued at $171,000 after buying an additional 15,515 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.